mesalamine has been researched along with Body Weight in 16 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
Excerpt | Relevance | Reference |
---|---|---|
" The ameliorating effect of the azo conjugate and therapeutic efficacy of the carrier system was evaluated in trinitrobenzenesulfonic acid-induced experimental colitis model." | 7.74 | Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats. ( Bhatt, L; Dhaneshwar, SS; Gairola, N; Kandpal, M; Vadnerkar, G, 2007) |
" The ameliorating effect of the azo conjugate and therapeutic efficacy of the carrier system was evaluated in trinitrobenzenesulfonic acid-induced experimental colitis model." | 3.74 | Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats. ( Bhatt, L; Dhaneshwar, SS; Gairola, N; Kandpal, M; Vadnerkar, G, 2007) |
" Dissolution studies of the prepared formulation conducted in simulated colonic fluid clearly demonstrated its superiority over the marketed, delayed release dosage forms of mesalamine." | 1.46 | Role of synbiotics in polysaccharide assisted colon targeted microspheres of mesalamine for the treatment of ulcerative colitis. ( Gulati, M; Kaur, R; Singh, SK, 2017) |
"The risk of colorectal cancer is increased in patients with inflammatory bowel diseases, especially those with ulcerative colitis (UC)." | 1.34 | 5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model. ( Endo, H; Fujisawa, T; Fujita, K; Ikeda, I; Inamori, M; Kubota, K; Nagashima, Y; Nakagama, H; Nakajima, A; Nozaki, Y; Saito, S; Takahashi, H; Tomimoto, A; Wada, K; Yoneda, M; Yonemitsu, K, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (12.50) | 18.2507 |
2000's | 8 (50.00) | 29.6817 |
2010's | 4 (25.00) | 24.3611 |
2020's | 2 (12.50) | 2.80 |
Authors | Studies |
---|---|
Dhaneshwar, SS | 1 |
Gairola, N | 1 |
Kandpal, M | 1 |
Vadnerkar, G | 1 |
Bhatt, L | 1 |
Su, XL | 1 |
Zhang, T | 1 |
Guo, S | 1 |
Wang, X | 2 |
Chen, L | 1 |
Wei, W | 1 |
Huang, S | 1 |
Xie, X | 1 |
Su, Y | 1 |
Pan, Z | 1 |
Li, Y | 1 |
Liang, J | 1 |
Zhang, M | 1 |
Pan, S | 1 |
Xu, B | 1 |
Li, L | 1 |
Chen, J | 1 |
Luo, X | 1 |
Zhou, L | 1 |
Mohanta, S | 1 |
Singh, SK | 2 |
Kumar, B | 1 |
Gulati, M | 2 |
Kumar, R | 1 |
Yadav, AK | 1 |
Wadhwa, S | 1 |
Jyoti, J | 1 |
Som, S | 1 |
Dua, K | 1 |
Pandey, NK | 1 |
Choi, KC | 1 |
Cho, SW | 1 |
Kook, SH | 1 |
Chun, SR | 1 |
Bhattarai, G | 1 |
Poudel, SB | 1 |
Kim, MK | 1 |
Lee, KY | 1 |
Lee, JC | 1 |
Balaha, M | 1 |
Kandeel, S | 1 |
Elwan, W | 1 |
Kaur, R | 1 |
Diamanti, A | 1 |
Basso, MS | 1 |
Gambarara, M | 1 |
Papadatou, B | 1 |
Bracci, F | 1 |
Noto, C | 1 |
Castro, M | 1 |
Chen, Y | 2 |
Liu, WL | 1 |
Zhou, TH | 1 |
Cai, JT | 1 |
Du, Q | 1 |
Wang, LJ | 1 |
Wu, JG | 1 |
Si, JM | 1 |
Mesker, T | 1 |
van Rheenen, PF | 1 |
Norbruis, OF | 1 |
Uitentuis, J | 1 |
Waalkens, HJ | 1 |
Gonera, G | 1 |
van Overbeek, LA | 1 |
Butler, J | 1 |
Rings, EH | 1 |
Jaiswal, A | 1 |
Parihar, VK | 1 |
Sudheer Kumar, M | 1 |
Manjula, SD | 1 |
Krishnanand, BR | 1 |
Shanbhag, R | 1 |
Unnikrishnan, MK | 1 |
Mladenovska, K | 1 |
Raicki, RS | 1 |
Janevik, EI | 1 |
Ristoski, T | 1 |
Pavlova, MJ | 1 |
Kavrakovski, Z | 1 |
Dodov, MG | 1 |
Goracinova, K | 1 |
Ikeda, I | 1 |
Tomimoto, A | 1 |
Wada, K | 1 |
Fujisawa, T | 1 |
Fujita, K | 1 |
Yonemitsu, K | 1 |
Nozaki, Y | 1 |
Endo, H | 1 |
Takahashi, H | 1 |
Yoneda, M | 1 |
Inamori, M | 1 |
Kubota, K | 1 |
Saito, S | 1 |
Nagashima, Y | 1 |
Nakagama, H | 1 |
Nakajima, A | 1 |
Kitano, A | 1 |
Matsumoto, T | 1 |
Oshitani, N | 1 |
Nakagawa, M | 1 |
Yasuda, K | 1 |
Watanabe, Y | 1 |
Tomobuchi, M | 1 |
Obayashi, M | 1 |
Tabata, A | 1 |
Fukushima, R | 1 |
Okabe, H | 1 |
Nakamura, S | 1 |
Obata, A | 1 |
Okawa, K | 1 |
Kobayashi, K | 2 |
Hirouchi, Y | 1 |
Kakamu, S | 1 |
Shoji, A | 1 |
Enomoto, M | 1 |
Hatakeyama, S | 1 |
Yonezawa, K | 1 |
Hedin, A | 1 |
Ehrsson, H | 1 |
Eksborg, S | 1 |
Finkel, Y | 1 |
Hildebrand, H | 1 |
Lidehäll, AK | 1 |
16 other studies available for mesalamine and Body Weight
Article | Year |
---|---|
Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats.
Topics: Animals; Azo Compounds; Body Weight; Colitis; Kinetics; Mesalamine; Molecular Structure; Organ Size; | 2007 |
Efficacy of Wumei Baijiang prescription on regulatory T cells / helper T cells Immune balance in mice with ulcerative coliti.
Topics: Animals; Body Weight; Colitis, Ulcerative; Colon; Disease Models, Animal; Drugs, Chinese Herbal; Int | 2022 |
Dahuang Mudan decoction repairs intestinal barrier in chronic colitic mice by regulating the function of ILC3.
Topics: Animals; Body Weight; Caco-2 Cells; Claudin-1; Colitis; Colitis, Ulcerative; Culture Media, Conditio | 2022 |
Efficacy of co-administration of modified apple polysaccharide and probiotics in guar gum-Eudragit S100 based mesalamine mini tablets: A novel approach in treating ulcerative colitis.
Topics: Animals; Body Weight; Colitis, Ulcerative; Colon; Drug Liberation; Galactans; Malus; Mannans; Mesala | 2019 |
Intestinal anti-inflammatory activity of the seeds of Raphanus sativus L. in experimental ulcerative colitis models.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Colitis, Ulcerative; Colon; Cytokines | 2016 |
Garlic oil inhibits dextran sodium sulfate-induced ulcerative colitis in rats.
Topics: Allyl Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; | 2016 |
Role of synbiotics in polysaccharide assisted colon targeted microspheres of mesalamine for the treatment of ulcerative colitis.
Topics: Animals; Body Weight; Colitis, Ulcerative; Colon; Diarrhea; Drug Carriers; Drug Liberation; Feces; F | 2017 |
Positive impact of blocking tumor necrosis factor alpha on the nutritional status in pediatric Crohn's disease patients.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Body Heig | 2009 |
Therapeutic effects of rectal administration of muscovite on experimental colitis in rats.
Topics: Administration, Rectal; Aluminum Silicates; Animals; Anti-Inflammatory Agents; Body Weight; Colitis; | 2009 |
Pediatric Crohn's disease activity at diagnosis, its influence on pediatrician's prescribing behavior, and clinical outcome 5 years later.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Body Height; Body Weight | 2009 |
5-Aminosalicylic acid reverses endosulfan-induced testicular toxicity in male rats.
Topics: Animals; Antidotes; Body Weight; Cell Shape; Endosulfan; Insecticides; L-Lactate Dehydrogenase; Leyd | 2005 |
Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles.
Topics: Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; B-Lymphocytes; Body Weight; Calcium; Ca | 2007 |
5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Colitis; Colitis, Ulcerative; Disease | 2007 |
Distribution and anti-inflammatory effect of mesalazine on carrageenan-induced colitis in the rabbit.
Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Carrageenan; Co | 1996 |
[Effects of mesalazine on liver carcinogenesis in medium-term bioassay using rats].
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Carcinogenicity | 1998 |
[A study of 5-ASA use among young patients with Crohn disease. Regular drug revision is of significance for all children with chronic disease].
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Child; Crohn Disease; Dose-Respons | 2001 |